Cooper Companies Inc (NYSE:COO) – Stock analysts at KeyCorp issued their Q1 2018 earnings per share estimates for Cooper Companies in a research report issued on Thursday. KeyCorp analyst M. Mishan anticipates that the medical device company will post earnings per share of $2.63 for the quarter. KeyCorp has a “Hold” rating on the stock. KeyCorp also issued estimates for Cooper Companies’ Q2 2018 earnings at $2.90 EPS, Q3 2018 earnings at $3.07 EPS and Q4 2018 earnings at $2.96 EPS.

Several other equities research analysts have also recently weighed in on COO. Robert W. Baird reissued a “buy” rating and issued a $273.00 price target (up previously from $267.00) on shares of Cooper Companies in a research note on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $277.00 target price for the company in a research note on Tuesday, August 29th. Jefferies Group set a $250.00 target price on Cooper Companies and gave the stock a “buy” rating in a research note on Thursday, August 17th. Oppenheimer reiterated a “hold” rating and issued a $250.00 price target on shares of Cooper Companies in a report on Tuesday, September 12th. Finally, Cleveland Research reiterated a “buy” rating on shares of Cooper Companies in a report on Tuesday, August 22nd. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $260.22.

Cooper Companies (NYSE COO) opened at $238.10 on Monday. Cooper Companies has a fifty-two week low of $159.23 and a fifty-two week high of $256.39. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. The stock has a market capitalization of $11,654.76, a PE ratio of 25.47, a price-to-earnings-growth ratio of 2.02 and a beta of 0.54.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.60% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Advisory Services Network LLC boosted its stake in Cooper Companies by 30.6% during the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after buying an additional 107 shares during the period. YorkBridge Wealth Partners LLC lifted its stake in Cooper Companies by 2.1% during the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after purchasing an additional 11 shares during the last quarter. Acrospire Investment Management LLC lifted its stake in Cooper Companies by 50.0% during the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after purchasing an additional 200 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in Cooper Companies during the third quarter worth about $163,000. Finally, Penserra Capital Management LLC lifted its stake in Cooper Companies by 13.0% during the second quarter. Penserra Capital Management LLC now owns 884 shares of the medical device company’s stock worth $211,000 after purchasing an additional 102 shares during the last quarter. Institutional investors own 96.78% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Brokers Issue Forecasts for Cooper Companies Inc’s Q1 2018 Earnings (COO)” was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/12/04/brokers-issue-forecasts-for-cooper-companies-incs-q1-2018-earnings-coo.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Earnings History and Estimates for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.